Biopharmaceutical lifecycle management platform IDBS (Guildford, UK) has announced a strategic partnership with software provider Scitara (MA, USA) to provide a combined laboratory data connectivity and instrument integration solution.
Workflows provided by IDBS’ Polar biopharmaceutical lifecycle management platform will be powered by Scitara Digital Laboratory Exchange, improving efficiency by removing manual processes and enabling high-quality, contextualized data, which will support laboratory decision-making. Solutions provided will include out-of-the-box instrument integration, equipment, informatics systems and enterprise platforms.
CEO of Scitara, Ajit Nagral, stated:
“Universal access to laboratory data is crucial to the success of science-based industry’s digital transformation journey…The Scitara Digital Laboratory Exchange (DLX) platform provides seamless peer-to-peer data connectivity for all laboratory instruments and applications, enables simple yet comprehensive data transformation and workflow automation, and creates a trusted digital trail of all lab data transactions for further analysis and decision-making. Our partnership with IDBS will enable their [biopharmaceutical lifecycle management] solution to interoperate with hundreds of systems connected to our laboratory data exchange backbone. We are excited to bring these capabilities to the IDBS user community and look forward to regulated and nonregulated customers reaping the benefits of our joint solution.”
Pietro Forgione, Vice President, Strategy at IDBS, commented:
“Scitara DLX will power the IDBS Polar platform by delivering best-in-class integration capabilities that uphold the highest standards of data integrity and remove roadblocks in capturing, contextualizing and gaining insights from data. By integrating with the IDBS cloud, Scitara DLX will also extend these capabilities to the broader IDBS cloud customer base.”
Source: IDBS press release https://www.idbs.com/2021/02/idbs-and-scitara-announce-strategic-partnership-dlx-and-polar/
The post Strategic partnership announced between IDBS and Scitara appeared first on Bioanalysis Zone.
Source link
more recommended stories
Autoimmune Disorders: ADA2 as a Therapeutic TargetAdenosine deaminase 2 (ADA2) has emerged.
Kaempferol: A Breakthrough in Allergy ManagementKaempferol, a dietary flavonoid found in.
Early Milk Cereal Drinks May Spur Infant Weight GainNew research published in Acta Paediatrica.
TaVNS: A Breakthrough for Chronic Insomnia TreatmentA recent study conducted by the.
First-of-Its-Kind Gene-Edited Pig Kidney: Towana’s New LifeSurgeons at NYU Langone Health have.
Just-in-Time Training Improves Success & Patient SafetyA study published in The BMJ.
ChatGPT Excels in Medical Summaries, Lacks Field-Specific RelevanceIn a recent study published in.
Study finds automated decision minimizes high-risk medicine combinations in ICU patientsA multicenter study coordinated by Amsterdam.
Study Discovers Connection Between Omicron Infection and Brain Structure Changes in MenA recent study in the JAMA.
Advancing COPD Prognosis: Deep Learning ModelsResearchers conducted a meta-analysis in a.
Leave a Comment